Moderna (MEX:MRNA) Interest Expense : MXN-453 Mil (TTM As of Dec. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Moderna Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Moderna's interest expense for the three months ended in Dec. 2024 was MXN -125 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2024 was MXN-453 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Moderna's Operating Income for the three months ended in Dec. 2024 was MXN -25,986 Mil. Moderna's Interest Expense for the three months ended in Dec. 2024 was MXN -125 Mil. Moderna did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Moderna Interest Expense Historical Data

The historical data trend for Moderna's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moderna Interest Expense Chart

Moderna Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Interest Expense

Get a 7-Day Free Trial

-196.65

-369.25

-565.38

-645.02

-500.54

Moderna Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Interest Expense	Get a 7-Day Free Trial															-101.85	-99.58	-109.92	-118.14	-125.13

Moderna Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-453 Mil.

Moderna (MEX:MRNA) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Moderna's Interest Expense for the three months ended in Dec. 2024 was MXN-125 Mil. Its Operating Income for the three months ended in Dec. 2024 was MXN-25,986 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2024 was MXN14,808 Mil.

Moderna's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

Moderna did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Moderna Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Moderna Inc (MEX:MRNA) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

MRNA:USA MRNA:Peru 1MRNA:Italy 0QFd:UK 0A45:UK 0QF:Germany M1RN34:Brazil MRNA:Austria

Address

325 Binney Street, Cambridge, MA, USA, 02139

Website

https://www.modernatx.com

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.